List of companies in Dementia Discovery Fund's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Alector is a San Francisco, California biotechnology company developing treatments for neurodegeneration and cancer through immuno-neurology and immuno-oncology. | ||||||
Small molecule drugs that target functional 3D RNA structures to treat human diseases. | ||||||
AstronauTx is a London-based biotechnology research company developing treatments for neurogenerative diseases. | ||||||
Nitrase Therapeutics is a Brisbane, California-based company offering a biopharmaceutical platform, Nitrome, designed to offer therapies against a broad variety of diseases. | ||||||
Platform for increasing protein production in the body using specialized translation enhancers. | ||||||
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases. | ||||||
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases. | ||||||
LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds. | ||||||
Amphista Therapeutics Limited is a company founded in 2017 by Alessio Ciulli. | ||||||
Alchemab Therapeutics is a United Kingdom-based company. | ||||||
Developer of targeted protein degradation (TPD) for the treatment of neurodegenerative diseases. | ||||||
Ribometrics is a Durham, North Carolina-based company. |
